Mark Cuban to publish Cost Plus Drug contracts

“Transparency,” a growing buzzword in the pharmaceutical industry, is making another premiere at Mark Cuban Cost Plus Drug Co.

Read the full post on Becker's Hospital Review | Healthcare News & Analysis